Antiseptics and Disinfectants Market

Report Description
Table of Contents

Report Description

The global antiseptics and disinfectants market size is projected to be USD 23.9 billion in 2021 and is likely to witness a CAGR of 20.95% during the forecast period. Increase in occurrence of hospital-acquired infections is a key driver for the growth of the global antiseptics and disinfectants market. Additionally, growth in awareness regarding home cleanliness and increasing use of surgical units and endoscope re processors are some of the other drivers propelling the market growth. Nevertheless, severe regulations relating to the use of antiseptics & disinfectants and lack of knowledge regarding the usage of antiseptics and disinfectants in developing are expected to restrain the global market growth.

Global Antiseptics and Disinfectants Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is segmented into alcohols & aldehyde products, chlorine compounds, quaternary ammonium compounds, enzyme, and others. In 2021, the quaternary ammonium compounds segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to increasing application of this type as a surface sterilizer in hospitals and laboratories as these composites help in controlling the spread of healthcare-associated infections worldwide. Enzyme segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to the rise in use of these enzymes for odor control that is normally caused due to chemical reactions.

By Product

Based on product, the market is segmented into medical device disinfectants, enzymatic cleaners, and surface disinfectants. In 2021, the medical device disinfectants segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This can be attributed to the increase in number of surgical procedures being conducted worldwide. Enzymatic cleaners segment is projected to grow at a profitable CAGR during the forecast period. This can be attributed to the rise in use of this cleaners as they help in preventing odour and these are most effective on bacterial surfaces thus it is mainly used in hospitals and clinics.

By Sales Channel

Based on sales channel, the market is categorized into FMCG and B2B. In 2021, the B2B segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to the rising preference of manufacturers more willing to directly sell their products to businesses and not to the end consumers worldwide. The FMCG segment is anticipated to grow at a profitable CAGR during the forecast period due to the increasing inclination of consumers who largely purchase FMCG products straight from retailers and wholesalers.

By End User

Based on distribution channel, the market is characterized into clinics, hospitals, and others. In 2021, the hospitals segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is due to the increase in cases of hospital-acquired infections worldwide. The clinics segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increase in healthcare expenditure by developed and developing economies results in growth in the number of clinics, which results in growing demand for antiseptics and disinfectants.

Regional Insights

In 2021, North America held the highest revenue share in the global market and is expected to keep its dominance during the forecast period. This is attributed to the presence of major manufacturers in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government, and accessibility of technologically advanced products in the region. Asia Pacific market is expected to grow at the fastest CAGR over the forecast period owing to the less stringent regulations, growing government and corporate investment in healthcare sector, increasing incidence of hospital-acquired infections, and availability of skilled labor forces at economic costs.

Competitor Insights

Some of the key players in the antiseptics and disinfectants market are The 3M Company (U.S.); Reckitt Benckiser Group plc (U.K.); Steris Corporation (U.S.); Kimberly-Clark Corporation (U.S.); Bio-Cide International, Inc. (U.S.); Cardinal Health, Inc. (U.S.); Becton, Dickinson and Company (U.S.); Johnson & Johnson Services Inc. (U.S.); The Clorox Company (U.S.); and DuPont de Nemours, Inc. (U.S.). The leading players operating in the antiseptics and disinfectants industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The antiseptics and disinfectants market report is categorized into the following segments and subsegments: